LOS ANGELES — Pharmaceutical drug maker GlaxoSmithKline PLC will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil complaints stemming from its use of kickbacks, misbranding and other misconduct to market drugs including Paxil, Wellbutrin and Advair, the U.S. government announced.
The agreement is the largest health care fraud settlement in history, spanning nearly every state, according to the Justice Department. It's also the largest payment ever by a drug company.
Kentucky joined 44 other states, the District of Columbia and the federal government in reaching the settlement, according to a news release from Attorney General Jack Conway's office.
Under the settlement, Kentucky receive more than $8.5 million for reimbursement of the state Medicaid program.